Bio-View Ltd (TLV:BIOV)
Israel · Delayed Price · Currency is ILS · Price in ILA 97.80
+1.40 (1.45%)
Jul 3, 2026, 1:44 PM IDT
Bio-View Market Cap
Bio-View has a market cap or net worth of 13.11 million as of July 2, 2026. Its market cap has decreased by -61.72% in one year.
Market Cap
13.11M
Enterprise Value
8.68M
Revenue
19.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
97.80
Market Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 13.11M, a decrease of -78.08%. That is a compound annual growth rate of -7.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 13.11M | -41.44% |
| Dec 31, 2025 | 22.38M | -37.30% |
| Dec 31, 2024 | 35.69M | -21.62% |
| Dec 31, 2023 | 45.53M | -10.12% |
| Dec 29, 2022 | 50.66M | 13.09% |
| Dec 30, 2021 | 44.79M | -20.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 116.13B |
| Danel (Adir Yeoshua) | 2.74B |
| Amal Holdings A.D. | 2.37B |
| BrainsWay | 1.84B |
| Erika Carmel-Tech | 21.21M |
| Purple Biotech | 18.65M |
| XTL Biopharmaceuticals | 17.98M |
| Nextage Therapeutics | 14.89M |